Al Malik Yaser M, Alharbi Awad S, Alfurayh Mohammed A, Aldalaan Abdulaziz A, Alzailaie Abdulazeez M, Alanazi Eid D, Abulaban Ahmad A, Makkawi Seraj O, Alanazi Asma A
From the College of Medicine (Al Malik, Alharbi, Alfurayh, Aldalaan, Alzailaie, Alanazi, Abulaban, Alanazi A), King Saud bin Abdulaziz University for Health Sciences, from King Abdullah International Medical Research Center (Al Malik, Alharbi, Alfurayh, Aldalaan, Alzailaie, Alanazi, Abulaban, Alanazi A), from the Department of Neurology (Al Malik, Abulaban), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs, Riyadh, from College of Medicine (Makkawi), King Saud bin Abdulaziz University for Health Sciences, from King Abdullah International Medical Research Center (Makkawi), and from the Department of Neuroscience (Makkawi), King Abdulaziz Medical City, Ministry of the National Guard-Health Affairs, Jeddah, Kingdom of Saudi Arabia.
Neurosciences (Riyadh). 2025 Apr;30(2):108-116. doi: 10.17712/nsj.2025.2.20240094.
To investigate whether Persons with MS (pwMS) in Saudi Arabia want to discuss their long-term prognosis (LTP) and the factors influencing this decision using a self-administered online questionnaire.
In this cross-sectional study, an online questionnaire was distributed from December 2022 to July 2023 across Saudi Arabia to determine pwMS interest in discussing their LTP. Participants included patients over 18 years, of any gender, diagnosed with MS. A nonprobability convenience sampling technique was used, with questionnaires sent through MS organizations and channels.
Almost two-thirds (66-68%) of the 375 respondents reported that their LTP had never been discussed during neurologist appointments and expressed uncertainty about it. Additionally, 23.5% noted discrepancies in information provided by different neurologists. Most (81.6%) expressed a desire for a prognostic tool at diagnosis. In this study, MS patients' desire to learn about a tool for assessing long-term prognosis was significantly associated with age, education level (<0.001), and gender (=0.02). A higher percentage of women (65.7%) showed interest in learning about the tool compared to men (34.3%).
While more than half of pwMS are curious about their prognosis, only about one-third have optimal discussions about LTP with neurologists. Many desire information on prognostic tools. Further research is needed to assess patients' knowledge of their prognosis and improve communication with physicians.
使用自行填写的在线问卷,调查沙特阿拉伯的多发性硬化症患者(pwMS)是否希望讨论其长期预后(LTP)以及影响这一决定的因素。
在这项横断面研究中,于2022年12月至2023年7月在沙特阿拉伯各地分发了一份在线问卷,以确定pwMS对讨论其LTP的兴趣。参与者包括18岁以上、任何性别的被诊断为MS的患者。采用非概率便利抽样技术,通过MS组织和渠道发送问卷。
375名受访者中,近三分之二(66%-68%)报告称,在与神经科医生的预约中从未讨论过他们的LTP,并对此表示不确定。此外,23.5%的人指出不同神经科医生提供的信息存在差异。大多数人(81.6%)表示在诊断时希望有一个预后工具。在这项研究中,MS患者了解评估长期预后工具的愿望与年龄、教育水平(<0.001)和性别(=0.02)显著相关。与男性(34.3%)相比,更高比例的女性(65.7%)对了解该工具表现出兴趣。
虽然超过一半的pwMS对自己的预后感到好奇,但只有约三分之一的人与神经科医生就LTP进行了最佳讨论。许多人希望获得有关预后工具的信息。需要进一步研究以评估患者对其预后的了解情况,并改善与医生的沟通。